Digital Health and Wearable Technology

1 Long Covid Wearable Device Study

  • Principal Investigator:: Julia Moore Vogel, PhD

  • Institution:: Scripps Research Institute, United States

  • Contact/URL:: https://solvecfs.org/exploring-current-me-cfs-and-long-covid-clinical-trials-on-national-clinical-trials-day/

  • Funder:: Institutional

  • Status:: Recruiting

  • Phase:: Observational, digital health

  • Cohort:: Adults with Long Covid, ME/CFS, or POTS

  • Mechanism/Focus:: Evaluates whether consumer wearable devices (e.g., Fitbit, Garmin) can support activity pacing, symptom management, and overall quality of life. Collects continuous physiological data (heart rate, activity, sleep) to quantify PEM triggers.

  • Primary Outcomes:: Pacing adherence; symptom management effectiveness; quality of life; PEM episode frequency

  • Estimated Completion:: Not yet announced

  • Timeline:: Recruitment ongoing as of 2026

  • Publication Medium:: Not yet announced

  • Document Relevance:: Ch. 17 (lifestyle interventions—pacing), Ch. 10 (cardiovascular/autonomic monitoring)

While not a biomarker or therapeutic study, this research addresses a critical practical question for ME/CFS management. Activity pacing is the primary non-pharmacological intervention (Chapter 17), yet objective tools to support pacing remain poorly validated. If wearable-derived metrics (heart rate variability, activity thresholds) can reliably predict PEM onset, this could transform day-to-day management for patients.